Teva Earnings On The Approach

Generic pharmaceutical giant Teva (TEVA​:NYSE) is set to report earnings in the coming sessions, leading to an uptick in volume and volatility for the company’s shares as management discusses results and issues forward-looking guidance.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.